Cell-free DNA analysis for noninvasive examination of trisomy: comparing 2 targeted methods

Am J Obstet Gynecol. 2022 Sep;227(3):539-541. doi: 10.1016/j.ajog.2022.05.024. Epub 2022 May 14.

Authors

Stéphanie Conotte¹, Hanane El Kenz¹, Jérôme De Marchin², Jacques C Jani³

Affiliations

¹ Department of Blood Transfusion, University Hospital Brugmann, Brussels, Belgium.
² Labocita, Centre Hospitalier Régional de la Citadelle, Liège, Belgium.
³ Department of Obstetrics and Gynecology, University Hospital Brugmann, Université Libre de Bruxelles, Place A. Van Gehuchten 4 1020 Brussels, Belgium. Electronic address: jackjani@hotmail.com.

PMID: 35577013
DOI: 10.1016/j.ajog.2022.05.024

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cell-Free Nucleic Acids*
Chromosomes, Human, Pair 18
Female
Humans
Pregnancy
Prenatal Diagnosis / methods
Sequence Analysis, DNA
Trisomy 13 Syndrome / diagnosis
Trisomy 13 Syndrome / genetics
Trisomy 18 Syndrome / diagnosis
Trisomy 18 Syndrome / genetics
Trisomy* / diagnosis
Trisomy* / genetics

Substances

Cell-Free Nucleic Acids